Acute and Chronic Toxicity of Ketoprofen Active Pharmaceutical Ingredient and Commercial Formulations to the Freshwater Photosynthetic Species Microcystis novacekii and Chlorella vulgaris
International Journal of Environmental Research and Public Health · 2026
DOI: 10.3390/ijerph23070829 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Environmental Research and Public Health, 2026. Verfasst von Gabriel Souza-Silva und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Federal University of Minas Gerais, Belo Horizonte 31270-901, Brazil. Hauptthemen laut MEDLINE: Ketoprofen, Chlorella vulgaris, Water Pollutants, Chemical, Microcystis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CSRD VA, National Council for Scientific and Technological Development, Brazilian Federal Agency for Support and Evaluation of Graduate Education.
Abstract (Originalsprache)
Ketoprofen (KET) is a non-steroidal anti-inflammatory drug frequently detected in surface waters and effluents, with the potential to impact trophic base organisms. This study evaluated the toxicity of KET, in its active pharmaceutical ingredient (API) form and in four commercial formulations (KET-1, KET-2, KET-3, and KET-4), on two freshwater species: the cyanobacterium Microcystis novacekii and the microalga Chlorella vulgaris. Cell growth assays, performed under acute (4 days) and chronic (14 days) conditions, showed that the API KET was the most toxic compound, especially for M. novacekii, with a chronic EC50 of 1.35 mg/L. The commercial formulations presented distinct toxicity profiles, suggesting the influence of excipients and synergistic or antagonistic interactions. For C. vulgaris, low acute toxicity was observed, with increased chronic effects at high concentrations and possible hormetic response at low doses. Risk quotient (RQ) calculations, based on environmental concentrations of KET, indicated low risk in surface and drinking water, but high risk in untreated hospital and wastewater treatment plant effluents, especially for M. novacekii. The results show that the complete formulation, exposure time, and target species are critical factors in the ecotoxicological risk assessment of pharmaceuticals in freshwater environments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmacy, Federal University of Minas Gerais, Belo Horizonte 31270-901, Brazil.
Förderung
- CSRD VA
- National Council for Scientific and Technological Development
- Brazilian Federal Agency for Support and Evaluation of Graduate Education
- Minas Gerais State Research Support Foundation
- Coordination for the Improvement of Higher Education Personnel
Zitieren
APA
Souza-Silva, G., Silva, M. I. G. A., Miranda, A. C. B., Alcântara, M. D., Souza, C. R., & Silveira, M. R. (2026). Acute and Chronic Toxicity of Ketoprofen Active Pharmaceutical Ingredient and Commercial Formulations to the Freshwater Photosynthetic Species Microcystis novacekii and Chlorella vulgaris. International Journal of Environmental Research and Public Health. https://doi.org/10.3390/ijerph23070829
Vancouver
Souza-Silva G, Silva MIGA, Miranda ACB, Alcântara MD, Souza CR, Silveira MR. Acute and Chronic Toxicity of Ketoprofen Active Pharmaceutical Ingredient and Commercial Formulations to the Freshwater Photosynthetic Species Microcystis novacekii and Chlorella vulgaris. International Journal of Environmental Research and Public Health. 2026. doi:10.3390/ijerph23070829
BibTeX
@article{SouzaSilva2026,
author = {Souza-Silva, Gabriel and Silva, Maria I G A and Miranda, Anna C B and Alcântara, Mariângela Domingos and Souza, Cléssius R and Silveira, Micheline Rosa},
title = {Acute and Chronic Toxicity of Ketoprofen Active Pharmaceutical Ingredient and Commercial Formulations to the Freshwater Photosynthetic Species Microcystis novacekii and Chlorella vulgaris},
journal = {International Journal of Environmental Research and Public Health},
year = {2026},
doi = {10.3390/ijerph23070829}
}
EUVIMED